Tag: Breye Therapeutics

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsBreye Therapeutics

Road Logistics Industry Outlook Report 2025 | Market to Reach Sales of $3.9 Trillion by 2034 – Rising Demand for Speed and Efficiency Fuels...

CertiK 行政總裁在香港交流策略後鞏固機構市場地位

Little Pepe Raises Over $3,500,000 as It Becomes Ethereum’s Hottest Meme Token of 2025

Tag: Breye Therapeutics

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us